Home Medicine Evaluation of the TEST 1 erythrocyte sedimentation rate system and intra- and inter-laboratory quality control using new latex control materials
Article
Licensed
Unlicensed Requires Authentication

Evaluation of the TEST 1 erythrocyte sedimentation rate system and intra- and inter-laboratory quality control using new latex control materials

  • Choong-Hwan Cha , Young Joo Cha , Chan-Jeoung Park , Hyun Kyung Kim , Eun-Jong Cha , Duck Hee Kim , Honghoon , Jae-Seol Jung , Mi-Jung Kim , Seongsoo Jang , Hyun-Sook Chi and Dong Soon Lee
Published/Copyright: May 12, 2010

Abstract

Background: The erythrocyte sedimentation rate (ESR) test has been considered to be a simple procedure, not requiring quality control (QC). However, QC is essential for accuracy and precision. We evaluated the TEST 1 ESR system and performed QC procedures using newly developed latex control materials in three hospitals.

Methods: Using tripotassium ethylenediaminetetraacetic acid blood samples (n=184), we compared TEST 1 ESR values with Westergren ESR data and evaluated intra-assay precision. Three levels of latex control materials were used to assess inter-assay precision. Reference range assessment was done using samples from 220 healthy individuals. Inter-laboratory QC with latex control materials in three hospitals was performed.

Results: Correlation between TEST 1 ESR and Westergren ESR results was good (p<0.001). Intra-assay precision [coefficients of variation (CV) 6.6%–21.7%] with patient samples and inter-assay precision (CV 0.0%–6.8%) with latex control materials were satisfactory. The reference ranges of 2–10 mm/h for males and 2–19 mm/h for females were established. Inter-laboratory QC data with latex control materials in three hospitals demonstrated good accuracy and satisfactory precision (CV 0.0%–14.4%).

Conclusions: Our results demonstrate that the TEST 1 QC is reliable and the latex control materials are valuable for inter-laboratory proficiency testing.

Clin Chem Lab Med 2010;48:1043–8.


Corresponding authors: Young Joo Cha, MD, Department of Laboratory Medicine, Chung-Ang University Hospital, 224-1 Heukseok-1dong, Dongjak-gu, Seoul 156-755, Korea Phone: +82-2-6299-2720, Fax: +82-2-6298-8630, Chan-Jeoung Park, MD, Department of Laboratory Medicine, Asan Medical Center, 388-1 Pungnap-2dong, Songpa-gu, Seoul 138-736, Korea Phone: +82-2-3010-4508, Fax: +82-2-478-0884,

Received: 2009-10-12
Accepted: 2010-1-21
Published Online: 2010-05-12
Published in Print: 2010-07-01

©2010 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. HIGHLIGHT: LABORATORY DIAGNOSTICS IN THE THIRD MILLENIUM: WHERE, HOW AND WHY
  2. Editorial
  3. Foreword
  4. Reviews
  5. Roots, development and future directions of laboratory medicine
  6. The “hospital central laboratory”: automation, integration and clinical usefulness
  7. Clinical pathology services: remapping our strategic itinerary
  8. Stat laboratory testing: integration or autonomy?
  9. Point-of-care testing in critical care: the clinician's point of view
  10. Reproductive-endocrine point-of-care testing: current status and limitations
  11. Laboratory testing in pharmacies
  12. Laboratory testing during critical care transport: point-of-care testing in air ambulances
  13. Self-monitoring of blood glucose with a focus on analytical quality: an overview
  14. Molecular diagnostics: between chips and customized medicine
  15. Evaluating laboratory diagnostic tests and translational research
  16. Integrated diagnostics: a conceptual framework with examples
  17. General Clinical Chemistry and Laboratory Medicine
  18. The European Register of Specialists in Clinical Chemistry and Laboratory Medicine: Guide to the Register, Version 3-2010
  19. The prevalence of preanalytical errors in a Croatian ISO 15189 accredited laboratory
  20. Indicators and quality specifications for strategic and support processes related to the clinical laboratory: four years' experience
  21. SKML-Quality Mark for point-of-care test (POCT) glucose meters and glucose meters for home-use
  22. PATHFAST™ NT-proBNP (N-terminal-pro B type natriuretic peptide): a multicenter evaluation of a new point-of-care assay
  23. Clinical implication of plasma neutrophil gelatinase-associated lipocalin (NGAL) concentrations in patients with advanced carotid atherosclerosis
  24. Evaluation of the TEST 1 erythrocyte sedimentation rate system and intra- and inter-laboratory quality control using new latex control materials
  25. Letter to the Editor
  26. Phlebotomy site haemolysis rates vary inversely with workload
Downloaded on 12.2.2026 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2010.162/html
Scroll to top button